These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9636390)

  • 1. Hyperacute skin allograft rejection in presensitized rats is abrogated by malononitrilamides.
    Schorlemmer HU; Kurrle R
    Transplant Proc; 1998 Jun; 30(4):963-7. PubMed ID: 9636390
    [No Abstract]   [Full Text] [Related]  

  • 2. Leflunomide abrogates accelerated heart allograft rejection in presensitized rats.
    Cheung A; Billingham M; Sherwood S; Brazelton T; Shorthouse R; Morris R
    Transplant Proc; 1997; 29(1-2):1294-5. PubMed ID: 9123313
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute skin graft rejection can be prevented and treated in rat models by malononitrilamides.
    Schorlemmer HU; Schwab W; Ruuth E; Kurrle R
    Transplant Proc; 1996 Dec; 28(6):3048-50. PubMed ID: 8962182
    [No Abstract]   [Full Text] [Related]  

  • 4. Malononitrilamides prevent the generation of oxygen radicals in mononuclear phagocytes and graft rejection in a rat model.
    Schorlemmer HU; Bartlett RR; Kurrle R
    Transplant Proc; 1999; 31(1-2):851-3. PubMed ID: 10083371
    [No Abstract]   [Full Text] [Related]  

  • 5. Coadministration of malononitrilamides and tacrolimus induces tolerance in a rat skin allograft model.
    Schorlemmer HU; Bartlett RR; Lindner JK; Kurrle R
    Transplant Proc; 1999; 31(1-2):1184-8. PubMed ID: 10083529
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term allograft survival and tolerance induction by the synergistic activity of malononitrilamides and tacrolimus.
    Schorlemmer HU; Bartlett RR; Lindner JK; Kurrle R
    Transplant Proc; 1998 Dec; 30(8):4099-103. PubMed ID: 9865312
    [No Abstract]   [Full Text] [Related]  

  • 7. Control of mouse-to-rat skin xenograft rejection by malononitrilamides.
    Schorlemmer HU; Kurrle R
    Transplant Proc; 1996 Dec; 28(6):3037-9. PubMed ID: 8962179
    [No Abstract]   [Full Text] [Related]  

  • 8. Malononitrilamides reduce IgM and IgG xenoantibodies and prolong skin xenograft survival in a mouse-to rat model.
    Schorlemmer HU; Kurrle R
    Transplant Proc; 1998 Jun; 30(4):976-9. PubMed ID: 9636394
    [No Abstract]   [Full Text] [Related]  

  • 9. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic activity of malononitrilamides with cyclosporine to control and reverse xenograft rejection.
    Schorlemmer HU; Kurrle R
    Int J Tissue React; 1997; 19(3-4):149-56. PubMed ID: 9506316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat.
    Bilolo KK; Ouyang J; Wang X; Zhu S; Jiang W; Qi S; Xu D; Hebert MJ; Bekersky I; Fitzsimmons WE; Chen H
    Transplantation; 2003 Jun; 75(11):1881-7. PubMed ID: 12811249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analogues of leflunomide's primary metabolite, the malononitrilamides, prevent the development of graft-versus-host disease.
    Schorlemmer HU; Bartlett RR; Kurrle R
    Transplant Proc; 1997; 29(1-2):1298-301. PubMed ID: 9123315
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of alloreactivity in the popliteal lymph node assay by malononitrilamides.
    Schorlemmer HU; Bartlett RR; Kurrle R
    Transplant Proc; 1998 Jun; 30(4):968-70. PubMed ID: 9636391
    [No Abstract]   [Full Text] [Related]  

  • 14. Mycophenolate mofetil's effect on accelerated heart allograft rejection and rejection markers in the rat.
    Chen H; Qi S; Xu D; Wu J; Busque S; Daloze P
    Transplant Proc; 1998 Jun; 30(4):1049-50. PubMed ID: 9636424
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppression of T-independent IgM xenoantibody formation by leflunomide during xenografting of hamster hearts in rats.
    Lin Y; Vandeputte M; Waer M
    Transplantation; 1998 Feb; 65(3):332-9. PubMed ID: 9484748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malononitrilamides 715 and 279 prevent accelerated cardiac allograft rejection synergistically with cyclosporin A in presensitized rats.
    Qi Z; Simanaitis M; Ekberg H
    Transpl Immunol; 1998 Jun; 6(2):94-100. PubMed ID: 9777697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of leflunomide and cyclosporine on myocutaneous allograft survival in the rat.
    Yeh LS; Gregory CR; Griffey SM; Lecouteur RA; Morris RE
    Transplantation; 1996 Sep; 62(6):861-3. PubMed ID: 8824490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malononitrilamides synergistically prevent acute and treat ongoing skin allograft rejection with cyclosporine.
    Schorlemmer HU; Ruuth E; Kurrle R
    Transpl Int; 1998; 11 Suppl 1():S340-4. PubMed ID: 9665012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malononitrilamides inhibit the development of various murine graft-vs-host diseases.
    Schorlemmer HU; Kurrle R; Bartlett RR
    Transplant Proc; 1996 Dec; 28(6):3043-7. PubMed ID: 8962181
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of different immunologic modalities on rat limb allotransplantation.
    Hou SM; Liou TC; Chu RM; Yeh LS
    Transplant Proc; 2002 Jun; 34(4):1320-1. PubMed ID: 12072350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.